4//SEC Filing
Naschitz Anat 4
Accession 0000899243-21-016227
CIK 0001785173other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 4:46 PM ET
Size
6.4 KB
Accession
0000899243-21-016227
Insider Transaction Report
Form 4
89bio, Inc.ETNB
Naschitz Anat
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-04-15+12,500→ 12,500 total(indirect: See footnote)Exercise: $24.16Exp: 2031-04-15→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 12,500 shares of the Issuer's Common Stock, one third of which will vest on April 15, 2022, with the remaining two thirds vesting in equal monthly installments over the following two years, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- [F2]These securities are held of record by Anat Naschitz ("Naschitz"), an employee of OrbiMed Advisors Israel II Limited ("Israel II Limited"). Pursuant to an agreement between Israel II Limited, OrbiMed Israel GP II, L.P. ("Israel II GP"), OrbiMed Advisors LLC ("OrbiMed Advisors"), and OrbiMed Capital GP VI LLC ("GP VI"), Naschitz is obligated to transfer these securities, or the economic benefit thereof, to Israel II Limited, Israel II GP, OrbiMed Advisors, and GP VI, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP and OrbiMed Israel Partners II, L.P.
Documents
Issuer
89bio, Inc.
CIK 0001785173
Entity typeother
Related Parties
1- filerCIK 0001792060
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 4:46 PM ET
- Size
- 6.4 KB